Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Assessor Blinded, Randomised Controlled Trial of Use of Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery(ACTION)

NCT04842994 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT04842994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Assessor Blinded, Randomised Controlled Trial of Use of Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery(ACTION)
Lead sponsor
Tata Memorial Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 16, 2019
Completion date
August 31, 2024
Enrollment
448 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of thyroid gland